Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
JSPR
JSPR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
JSPR News
Jasper Therapeutics Reports Fiscal Year 2025 Results and Corporate Update
20h ago
Newsfilter
Jasper Therapeutics Q4 Earnings Beat Expectations with Significant Cash Reserves
19h ago
seekingalpha
UBS Initiates Neutral Coverage on Jasper Therapeutics with $1.50 Target
1d ago
Yahoo Finance
UBS Initiates Coverage of Jasper Therapeutics Inc with Neutral Rating and $1.50 Price Target
Mar 23 2026
moomoo
Jasper Appoints Jeet Mahal as CEO, Focuses on Chronic Urticaria Treatment
Jan 07 2026
Globenewswire
Jasper Stock Soars Following Positive Results from New Asthma Study
Dec 02 2025
Benzinga
Jasper Reports Positive ETESIAN Study Data for Briquilimab, 180mg Dose Shows Significant Asthma Improvement
Dec 02 2025
Globenewswire
Jasper Reports Positive ETESIAN Study Data for Briquilimab, 180mg Dose Shows Significant Asthma Improvement
Dec 02 2025
Newsfilter
Jasper Therapeutics Announces Encouraging Findings for Briquilimab in Phase 1b Study of Allergic Asthma
Dec 02 2025
NASDAQ.COM
Jasper Therapeutics to Hold Webinar Showcasing Results from BEACON and ETESIAN Studies
Dec 02 2025
NASDAQ.COM
Post-Market Highlights: Jasper, NRx, Unicycive, Spruce, Evaxion, Solana, and Protara See Gains After Trading Hours
Dec 02 2025
NASDAQ.COM
Jasper Therapeutics to Host Webinar Presenting briquilimab Study Findings
Dec 01 2025
Newsfilter
Bragar Eagel & Squire Investigates Officers and Directors of Driven Brands and Jasper Therapeutics for Long-Term Stockholders, Urging Investors to Reach Out to the Firm
Nov 22 2025
Globenewswire
IMPORTANT NOTICE for NX, JSPR, and KBR: The Law Offices of Frank R. Cruz Notifies Investors About Class Action Lawsuits for Shareholders
Nov 18 2025
Globenewswire
JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces Opportunity for Jasper Therapeutics, Inc. Investors Facing Significant Losses to Initiate Class Action Lawsuit
Nov 18 2025
Globenewswire
Bragar Eagel & Squire, P.C. Alerts Jasper, KBR, Spirit, and Molina Stockholders About Approaching Deadlines and Encourages Investors to Reach Out to the Firm
Nov 17 2025
Globenewswire
Show More News
